Description
JAINEX AAMCOL LTD. announces rights issue offering 1 equity share at Rs. 120 (Rs. 10 face value + Rs. 110 premium) for every 2 shares held, with record date November 20, 2025.
Summary
JAINEX AAMCOL LTD. (BSE Code: 505212) has announced a rights issue of equity shares with a record date of November 20, 2025. Existing shareholders will be entitled to subscribe to 1 new equity share for every 2 equity shares held at a price of Rs. 120 per share (face value Rs. 10 plus premium of Rs. 110). Trading in the company’s shares will be conducted on an ex-rights basis from November 20, 2025.
Key Points
- Company: JAINEX AAMCOL LTD. (BSE Code: 505212)
- Rights entitlement ratio: 1:2 (1 new share for every 2 shares held)
- Issue price: Rs. 120 per share (Rs. 10 face value + Rs. 110 premium)
- Record date: November 20, 2025
- Ex-rights date: November 20, 2025
- Settlement number: DR-760/2025-2026
- Security type: Dematerialised securities in rolling settlement segment
Regulatory Changes
No regulatory changes introduced. This is a standard corporate action notification under existing BSE regulations for rights issues.
Compliance Requirements
- Trading members must ensure all transactions in JAINEX AAMCOL LTD. equity shares are executed on an ex-rights basis from November 20, 2025
- Trading members must take note of the record date and settlement details for proper trade processing
- Shareholders on record as of November 20, 2025 will be eligible to participate in the rights issue
Important Dates
- November 17, 2025: Circular notification date
- November 20, 2025: Record date for rights issue eligibility
- November 20, 2025: Ex-rights trading begins (Settlement DR-760/2025-2026)
Impact Assessment
Shareholder Impact: Existing shareholders holding shares as of the record date will receive rights entitlements allowing them to subscribe to additional shares at Rs. 120 per share. This represents a capital raising opportunity for the company and a subscription opportunity for shareholders.
Trading Impact: From November 20, 2025, the stock will trade ex-rights, meaning new buyers will not be entitled to participate in the rights issue. This typically results in a price adjustment reflecting the value of the rights being separated from the stock.
Market Impact: Limited to shareholders of JAINEX AAMCOL LTD. The rights issue allows the company to raise capital while giving existing shareholders pre-emptive rights to maintain their proportional ownership. The premium of Rs. 110 over face value indicates the pricing relative to prevailing market conditions.
Impact Justification
Standard rights issue announcement affecting existing shareholders of JAINEX AAMCOL LTD. with specific entitlement ratio and pricing. Medium impact limited to company's shareholder base.